Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cesarean section IUD insertion.

V Ruiz-velasco, C Garcia, H Castro

    Contraceptive Delivery Systems
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.

    Journal of molecular biology·2001
    Same author

    Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.

    International journal of antimicrobial agents·2001
    Same author

    Serum leptin levels in cattle with different nutritional conditions.

    Nutrition research (New York, N.Y.)·2001
    Same author

    A web page to teach neurology and neuropathology to medical students.

    Neuropathology and applied neurobiology·2001
    Same author

    Constituents of Coriaria ruscifolia fruits.

    Fitoterapia·2001
    Same author

    Four-week oral toxicity studies of the new quinolone antibacterial agent cetefloxacin tosylate in rats and marmoset monkeys.

    Arzneimittel-Forschung·2001

    Inserting the ML Cu 250 IUD during cesarean section is a safe and effective contraceptive method. This study shows high success rates and patient acceptability with no increased complications.

    Area of Science:

    • Reproductive Health
    • Obstetrics and Gynecology
    • Contraception

    Background:

    • Cesarean sections present an opportunity for immediate postpartum contraception.
    • Intrauterine devices (IUDs) are a long-acting reversible contraceptive (LARC) method.
    • Evaluating the safety and efficacy of IUD insertion concurrent with cesarean delivery is crucial.

    Purpose of the Study:

    • To assess the safety and effectiveness of the ML Cu 250 IUD when inserted during cesarean section.
    • To evaluate patient acceptability and continuation rates of this contraceptive method.
    • To determine any impact on postoperative morbidity, lactation, or menstrual patterns.

    Main Methods:

    • A prospective trial involving 154 volunteers undergoing cesarean section.
    Keywords:
    Contraception TerminationEndometritisInfectionsIudMenstrual CycleMenstruationPuerperiumPulmonary EmbolismReproduction

    Related Experiment Videos

  • ML Cu 250 IUD insertion during cesarean delivery (planned and unplanned).
  • Follow-up at 1, 3, 6, 12, and 24 months post-insertion.

    • Main Results:

    • No increase in hospitalization time or postoperative morbidity observed.
    • Maternal lactation remained unaltered.
    • High success rates: 52% normal menstruation at 1 year, increasing to 62.5% at 2 years.
    • Low removal rates (2.6% medical, 5.2% patient desire) and expulsion rates (2.6%).
    • No pregnancies detected during the study period.

    Conclusions:

    • Cesarean section insertion of the ML Cu 250 IUD is a highly effective and acceptable contraceptive procedure.
    • The method does not adversely affect key maternal health indicators.
    • Widespread adoption of this approach is recommended for improved postpartum contraception.